Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4565 Evaluation of duodenal neuroendocrine tumours according to MCSC register

Introduction: Neuroendocrine tumours (NETs) of the duodenum are relatively rare tumours and account for 4% of all gastroenteropancreatic NETs.

Conference:

Presenting Author:

Authors: Petrova A, Salimgereeva D, Feidorov I, Konyakhina A,

Keywords: duodenal, register, atrophic gastritis, NET, grade, papilla,

#4451 The management of well-differentiated gastroenteropancreatic neuroendocrine tumours in a tertiary centre – The contribution of radionuclide therapy

Introduction: Neuroendocrine tumours represent a heterogenous group of tumours with different locations, whose management is necessary to identify specific parameters that determine the choice of optimal treatment.

Conference:

Presenting Author: Oana Stefania S

Authors: Oana Stefania S, Corin B, Victoria V, Sofia L,

Keywords: GEP-NET, well-differentiated, PRRT, Cromogranine A, Serotonin, RECIST 1.1,

#4094 Peptide Receptor Radionuclide Therapy improves progression free and overall survival in patients who progress after resection of gastroenteropancreatic NETs

Introduction: Peptide Receptor Radionuclide Therapy (PRRT) improves progression-free-survival (PFS) in advanced midgut neuroendocrine tumors (NETs). Whether PRRT specifically improves survival in surgically managed gastroenteropancreatic (GEP) NET with progression is unknown.

Conference:

Presenting Author: Howe J

Authors: Borbon L, Sherman S, Breheny P, Ear P, Menda Y,

Keywords: gastroenteropancreatic, resection, progression, PRRT, neuroendocrine tumor,

#3753 The additive value of F-18 fluorodeoxyglucose PET imaging in grade 1 gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Introduction: Grade 1 gastroenteropancreatic NETs (GEP-NETs) exhibit better prognosis compared to Grade 2-3 tumors. High uptake in 68Ga-DOTATOC PET imaging is commonly seen in well-differentiated tumors whereas uptake in F-18 FDG PET imaging is associated with aggressive behaviour.

Conference:

Presenting Author:

Authors: Liotsou T, Metaxas M, Georgakopoulos A, Tsoli M, Panagaki M,

Keywords: F-18 FDG-PET, grade 1 GEP-NET, prognosis,

#3427 Updated morphological and immunohistochemical profile of neuroendocrine tumors developed in ovarian teratomas: A large series of a rare disease

Introduction: Ovarian carcinoid tumors are rare, often arising within a mature teratoma. No recent reevaluation of the immunophenotype of these tumors with new markers available has been performed.

Conference:

Presenting Author: Couvelard A

Authors: Leclerc J, Genestie C, Hentic O, Scoazec J, Couvelard A,

Keywords: NET, carcinoid, Ki67, ovarian teratoma, gynecology, pathology,